Page last updated: 2024-12-07
s-(4-nitrobenzyl)glutathione
Description
S-(4-nitrobenzyl)glutathione: metabolite of 4-nitrotoluene [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
S-(4-nitrobenzyl)glutathione : An S-substituted glutathione in which the thiol hydrogen of glutathione is replaced by a 4-nitrobenzyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 97538 |
CHEBI ID | 87407 |
SCHEMBL ID | 2089788 |
MeSH ID | M0115599 |
Synonyms (19)
Synonym |
6803-19-6 |
s-(p-nitrobenzyl)glutathione |
GTB , |
s-(4-nitrobenzyl)glutathione |
DB03686 |
(2s)-2-amino-5-[[(2r)-1-(carboxymethylamino)-3-[(4-nitrophenyl)methylsulfanyl]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid |
A835983 |
glycine, n-(n-l-gamma-glutamyl-s-((4-nitrophenyl)methyl)-l-cysteinyl)- |
nsc 131122 |
SCHEMBL2089788 |
l-gamma-glutamyl-s-[(4-nitrophenyl)methyl]-l-cysteinylglycine |
CHEBI:87407 |
l-gamma-glutamyl-s-(4-nitrobenzyl)-l-cysteinylglycine |
Q27159603 |
s-(p-nitrobenzyl)-glutathione |
(s)-2-amino-5-((r)-1-(carboxymethylamino)-3-(4-nitrobenzylthio)-1-oxopropan-2-ylamino)-5-oxopentanoic acid |
CS-0616363 |
HY-148208 |
(s)-2-amino-5-(((r)-1-((carboxymethyl)amino)-3-((4-nitrobenzyl)thio)-1-oxopropan-2-yl)amino)-5-oxopentanoic acid |
Drug Classes (3)
Class | Description |
C-nitro compound | A nitro compound having the nitro group (-NO2) attached to a carbon atom. |
organic sulfide | Compounds having the structure RSR (R =/= H). Such compounds were once called thioethers. |
S-substituted glutathione | A glutathione derivative that is glutathione in which the hydrogen of the thiol has been replaced by any other group. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.82
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.82 (24.57) | Research Supply Index | 2.08 (2.92) | Research Growth Index | 4.90 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |